Cellectis (CLLS) Change in Intangibles (2015 - 2025)
Cellectis' (CLLS) quarterly Change in Intangibles came in at -$1.2 million in Q3 2025, down 4050.0% year-on-year from $29417.7 in Q3 2024, and down 4050.0% quarter-over-quarter from -$28000.0 in Q3 2024.
Cellectis (CLLS) Change in Intangibles (2015 - 2025) Analysis & Trends
Cellectis' Change in Intangibles history runs 10 years deep, the most recent figure standing at -$1.2 million for Q3 2025.
- On a quarterly basis, Change in Intangibles fell 4050.0% year-over-year to -$1.2 million in Q3 2025; TTM through Sep 2025 was -$1.2 million, a 438.16% decrease from a year earlier, with the FY2016 full-year figure at -$337652.6, down 249.4% from the prior year.
- Change in Intangibles eased to -$1.2 million in Q3 2025 per CLLS's latest filing, from -$28000.0 in the prior quarter.
- Across five years, Change in Intangibles topped out at -$1000.0 in Q2 2021 and bottomed at -$1.2 million in Q3 2025.
- The 4-year median for Change in Intangibles is -$37000.0 (2024), against an average of -$324285.7.
- Across the five-year window, Change in Intangibles sank 42750.0% in 2021 and surged 80.98% in 2022, its largest moves.
- Year by year, Change in Intangibles stood at -$857000.0 in 2021, then jumped by 80.98% to -$163000.0 in 2022, then soared by 82.82% to -$28000.0 in 2024, then plunged by 4050.0% to -$1.2 million in 2025.
- Per Business Quant, the three latest CLLS Change in Intangibles figures stand at -$1.2 million (Q3 2025), -$28000.0 (Q3 2024), and -$37000.0 (Q1 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -66,508.31 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.16 Mn |
| Sep 30, 2025 | -1.16 Mn |
| Sep 30, 2024 | -28,000.00 |
| Sep 30, 2024 | -28,000.00 |
| Mar 31, 2024 | -37,000.00 |
| Mar 31, 2024 | -37,000.00 |
| Sep 30, 2022 | -163,000.00 |
| Sep 30, 2022 | -163,000.00 |
| Sep 30, 2021 | -857,000.00 |
| Sep 30, 2021 | -857,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | -22,000.00 |
| Mar 31, 2021 | -22,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Jun 30, 2020 | 2,000.00 |
| Jun 30, 2020 | 2,000.00 |
| Mar 31, 2020 | -43,000.00 |
| Mar 31, 2020 | -43,000.00 |